← Open Payments lookup

MICHAEL KARLS: Open Payments

NPI 1801804737 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,333 in 168 payments from 18 companies in 2025. Trend: 2023 $3,273 · 2024 $5,312 · 2025 $4,333

Food & beverage: $4,154Education: $179
CompanyPaymentsAmount
ABBVIE INC.21$578
GENZYME CORPORATION16$465
Arcutis Biotherapeutics, Inc.25$449
Janssen Biotech, Inc.8$435
LEO Pharma Inc.18$401
SUN PHARMACEUTICAL INDUSTRIES INC.10$343
Galderma Laboratories, L.P.14$339
UCB, Inc.14$266
Lilly USA, LLC8$180
Regeneron Healthcare Solutions, Inc.8$179

Products named: DUPIXENT, Zoryve, TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, Bimzelx, ADBRY.

Industry payments across CA — which companies pay providers there.